| CAS | 1155866-55-9 |
| Sequence | N-2-[4-[[[(2-methylphenyl)amino]carbonyl]amino]phenyl]acetyl-Leu-Asp-Val-Pro-Ala-Ala-Lys-OH |
| Sequence Single | N-2-[4-[[[(2-methylphenyl)amino]carbonyl]amino]phenyl]acetyl-Leu-DVPAAK |
| Molecular Formula | C48H70N10O12 |
| Molecular Weight | 979.13 |
| Technology | Synthetic |
| Storage | -20°C, avoid light, cool and dry place |
| Description | LDV is a α4β1 integrin (VLA-4) ligand (Kd ~ 12 nM). Non-fluorescent derivative of LDV FITC. |
| References | 1. Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation. Chigaev et al (2009). J.Biol.Chem. 284 14337 PMID: 19251697 2. Conformational mAb as a tool for integrin ligand discovery. Ben H Njus, et al. Assay Drug Dev Technol. 2009 Oct;7(5):507-15. 3. LDV peptidomimetics equipped with biotinylated spacer-arms: synthesis and biological evaluation on CCRF-CEM cell line. Estelle Gérard, et al. Bioorg Med Chem Lett. 2012 Jan 1;22(1):586-90. |